Home > Healthcare > Healthcare IT > Health Services > treatment planning systems and advanced image processing market
Get a free sample of Treatment Planning Systems and Advanced Image Processing Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Treatment Planning Systems and Advanced Image Processing Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The market is a fragmented, dynamic, and rapidly evolving sector, characterized by significant technological advancements and competitive activities among leading players. Key market participants, including Accuray Incorporated, Elekta AB, GE HealthCare Technologies Inc., Koninklijke Philips N.V., and Siemens Healthineers AG, are driving innovation through advanced treatment planning and image processing technologies, expanded product offerings, and strategic collaborations. Companies that successfully leverage these opportunities and address market challenges are well-positioned for success in the competitive treatment planning systems and advanced image processing landscape.
Some of the eminent market participants operating in the treatment planning systems and advanced image processing industry include:
North America treatment planning systems and advanced image processing market will reach USD 1.9 billion by 2032 due to the well-established healthcare infrastructure.
The oncology segment in the market generated USD 994.8 million in 2023 and is expected to grow at 8.8% CAGR during 2024-2032 owing to the ongoing innovations in imaging technologies.
The treatment planning systems and advanced image processing market size was valued at USD 2 billion in 2023 and is estimated to grow at 8.6% CAGR from 2024 to 2032 due to the rising prevalence of cancer.
Accuray Incorporated, Agfa-Gevaert Group, Brainlab AG, Canon Medical Systems Corporation, C-RAD AB, Elekta AB, GE HealthCare Technologies Inc., Hitachi, Ltd., IBA Radiopharma Solutions, IntraOp Medical Corporation, and Koninklijke Philips N.V among others